174.19
price up icon0.54%   0.935
 
loading

Finanzdaten der Guardant Health Inc-Aktie (GH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
11.04%
334.98
301.67 281.27 265.20 232.09
Cost Of Revenue
10.51%
115.95
104.92 99.49 93.59 81.20
Research and Development
6.04%
96.53
91.04 98.26 89.96 -
Costs And Expenses
9.71%
464.10
423.01 402.07 364.19 338.50
Operating Income/Loss
6.40%
-129.12
-121.35 -120.81 -98.99 -106.41
Income/Loss From Continuing Operations Before Tax
7.39%
-119.96
-111.70 -130.22 -92.59 -99.86
Income Tax Expense/Benefit
50.27%
0.185
0.372 -1.727 0.136 0.038
Net Income/Loss
7.20%
-120.14
-112.08 -128.49 -92.72 -99.90
Basic Average Shares
1.21%
132.87
131.27 - 124.81 124.11
Diluted Average Shares
1.21%
132.87
131.27 - 124.81 124.11
Basic Earnings Per Share
5.88%
-0.90
-0.85 - -0.74 -0.80
Diluted Earnings Per Share
5.88%
-0.90
-0.85 - -0.74 -0.80
DGX DGX
$241.25
price down icon 0.70%
LH LH
$329.30
price down icon 0.18%
$674.60
price down icon 0.32%
$159.89
price down icon 0.31%
CRL CRL
$355.92
price down icon 0.38%
$183.87
price up icon 0.05%
Kapitalisierung:     |  Volumen (24h):